
Human Mesenchymal Stem Cell-Derived Exosomes as Engineering Vehicles of Daunorubicin for Targeted c-Mpl+ AML Therapy
Introduction Acute myeloid leukemia (AML) is an aggressive and highly heterogeneous hematopoietic malignancy resulting from the malignant transformation of hematopoietic stem or progenitor cells.1 Despite significant advancements in chemotherapy, targeted …